When the cytolytic activity was evaluated longitudinally by dynamic monitoring using IncuCyte, UTD-NK cells exhibited AML control at best, while CD33-CAR-NK cells efficiently eradicated OCI-AML2 cells even at the unfavorable E:T-ratio of 1:5 (Fig. 1G). The gene discussed is CD33; the disease is acute myeloid leukemia.